Quality Control Testing, Characterization and Critical Quality Attributes of Adeno‐Associated Virus Vectors Used for Human Gene Therapy
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Quality Control Testing, Characterization and Critical Quality Attributes of Adeno‐Associated Virus Vectors Used for Human Gene Therapy
Authors
Keywords
-
Journal
Biotechnology Journal
Volume 16, Issue 1, Pages 2000022
Publisher
Wiley
Online
2020-11-05
DOI
10.1002/biot.202000022
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Codon Modification and PAMPs in Clinical AAV Vectors: The Tortoise or the Hare?
- (2020) J. Fraser Wright MOLECULAR THERAPY
- Engineering adeno-associated virus vectors for gene therapy
- (2020) Chengwen Li et al. NATURE REVIEWS GENETICS
- Moving Forward After Two Deaths in a Gene Therapy Trial of Myotubular Myopathy
- (2020) James M. Wilson et al. HUMAN GENE THERAPY
- Broader Implications of Progressive Liver Dysfunction and Lethal Sepsis in Two Boys following Systemic High-Dose AAV
- (2020) Leon Morales et al. MOLECULAR THERAPY
- Methylation Status of the Adeno-Associated Virus Type 2 (AAV2)
- (2019) Renáta Tóth et al. Viruses-Basel
- Adeno-associated Virus (AAV) versus Immune Response
- (2019) Joseph Rabinowitz et al. Viruses-Basel
- Type I IFN Sensing by cDCs and CD4+ T Cell Help Are Both Requisite for Cross-Priming of AAV Capsid-Specific CD8+ T Cells
- (2019) Jamie L. Shirley et al. MOLECULAR THERAPY
- The Effect of CpG Sequences on Capsid-Specific CD8+ T Cell Responses to AAV Vector Gene Transfer
- (2019) ZhiQuan Xiang et al. MOLECULAR THERAPY
- Toll-like Receptor 9 Contains Two DNA Binding Sites that Function Cooperatively to Promote Receptor Dimerization and Activation
- (2018) Umeharu Ohto et al. IMMUNITY
- Pharmacology of Recombinant Adeno-associated Virus Production
- (2018) Magalie Penaud-Budloo et al. Molecular Therapy-Methods & Clinical Development
- Deamidation of Amino Acids on the Surface of Adeno-Associated Virus Capsids Leads to Charge Heterogeneity and Altered Vector Function
- (2018) April R. Giles et al. MOLECULAR THERAPY
- CpG-depleted adeno-associated virus vectors evade immune detection
- (2013) Susan M. Faust et al. JOURNAL OF CLINICAL INVESTIGATION
- Native Molecular State of Adeno-Associated Viral Vectors Revealed by Single-Molecule Sequencing
- (2011) Philipp Kapranov et al. HUMAN GENE THERAPY
- Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges
- (2011) Federico Mingozzi et al. NATURE REVIEWS GENETICS
- Assessing the potential for AAV vector genotoxicity in a murine model
- (2010) H. Li et al. BLOOD
- The TLR9-MyD88 pathway is critical for adaptive immune responses to adeno-associated virus gene therapy vectors in mice
- (2009) Jiangao Zhu et al. JOURNAL OF CLINICAL INVESTIGATION
- Undetectable Transcription of cap in a Clinical AAV Vector: Implications for Preformed Capsid in Immune Responses
- (2008) Bernd Hauck et al. MOLECULAR THERAPY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started